Proteomics Market to Surge at 16.8% CAGR Through 2031, Powered by Personalized Medicine and Technological Breakthroughs | Danaher, Agilent Technologies, Bruker, Promega Corporation, Waters Corporation, PerkinElmer Inc

Proteomics Market is estimated to grow at a CAGR of 16.8% during the forecast period 2024-2031.

The Proteomics Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth reports that help clients navigate complex market dynamics, drive strategic growth, and seize new opportunities in an ever-evolving global landscape.

Download your exclusive sample report today: (corporate email gets priority access): https://datamintelligence.com/download-sample/proteomics-market?sg

Key Market Drivers:
Advancements in Mass Spectrometry and Bioinformatics

Continuous innovation in analytical techniques, particularly in mass spectrometry, protein microarrays, and chromatography, has enhanced protein profiling and quantification accuracy. Coupled with improved bioinformatics tools, these developments streamline data analysis and biomarker discovery.

Rising Demand for Personalized Medicine

As healthcare shifts toward personalized and precision therapies, proteomics plays a critical role in identifying disease-specific protein expressions, aiding in targeted drug development and diagnostics.

Growth in Drug Discovery and Development

Pharmaceutical and biotechnology companies are leveraging proteomics in early-stage drug discovery, target identification, and validation. This is fueling demand for proteomic platforms and services globally.

Increased Focus on Biomarker Discovery

The need for early and accurate disease detection, especially in cancer, cardiovascular, and neurodegenerative conditions, is driving biomarker research, where proteomics is a vital tool.

Supportive Government and Academic Funding

Numerous public and private funding programs continue to support proteomic research, especially in developed countries. These efforts enhance infrastructure and accelerate translational research projects.

Proteomics Market - Geographical Share
The global proteomics market is witnessing widespread growth across multiple regions, driven by advances in biotechnology, increasing research funding, and growing applications in drug discovery and diagnostics.

North America commands a dominant share of the global proteomics market, primarily due to strong government support for life sciences research, a well-established biopharmaceutical sector, and high adoption of advanced technologies. The U.S. contributes the largest revenue, fueled by initiatives in personalized medicine and investments in proteogenomics.

Europe holds a significant share, led by countries like Germany, the UK, and France. The region benefits from collaborative research efforts among academic institutions and the healthcare industry. The EU's focus on precision medicine, coupled with an increasing number of biomarker validation studies, continues to support market expansion.

Asia-Pacific is emerging as the fastest-growing region in the proteomics market. Countries such as China, India, and Japan are increasing investments in genomic and proteomic research. Government initiatives promoting biotech innovation, growing clinical research infrastructure, and rising disease burden contribute to the market's rapid development.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/proteomics-market?sg

Strategic Players Driving the Proteomics Market: Thermo Fisher Scientific Inc., Danaher, Agilent Technologies, Inc., Bio-Rad Laboratories Inc, Bruker, Merck KGaA, Promega Corporation, Waters Corporation, PerkinElmer Inc and Panacea Biotec.

Product Launches & Technology Advances (2024-2025):

Biognosys unveiled Spectronaut 20 and SpectroMine 5 in May 2025, incorporating a new "Kuiper" search engine optimized for immunopeptidomics, with up to 80% more peptide IDs, improved timsTOF‐support, Linux and cloud workflows, and enhanced data visualization.

Quantum‐Si, Inc. rolled out its Platinum Pro benchtop protein sequencer in January 2025, offering integrated sequencing and analysis in a streamlined workflow for proteoform and drug discovery applications.

In April 2025, Technical University of Munich researchers released MS2Bac, a novel software tool that maps tryptic peptides in mass spec data for bacterial species identification with perfect accuracy enhancing microbial proteomics diagnostics.

Strategic Partnerships & Collaborations:

Biognosys confirmed a strategic collaboration with SISCAPA Assay Technologies in May 2025, integrating SISCAPA's targeted, high‐sensitivity protein quantification with Biognosys' DIA mass spec workflows, delivering complete proteome access in one solution.

In January 2025, Sapient partnered with Alamar Biosciences to enhance targeted proteomics services using Alamar's NULISATM assays, enabling precise detection of low‐abundance neuroinflammatory markers in drug discovery pipelines.

Quantum‐Si and IDEX Health & Science began a collaboration in early 2025 to co‐develop the optics module for Quantum‐Si's upcoming ProteusTM proteomics platform, expected in late 2026.
Research Methodology:

The global Proteomics Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.

Segment Covered in the Proteomics Market:

By Instrumentation Technology (Chromatography, Protein Microarrays, Spectroscopy, Electrophoresis, X-Ray Crystallography, Surface Plasmon Resonance, Protein Fractionation, Others)

By Application (Drug, Discovery, Clinical Diagnostics, Others)

By Services and Software (Bioinformatics Software and Services, Core Proteomics Services, Reagents)

By End User (Hospitals, Research Laboratories, Biopharmaceutical Companies)

By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?sg

Regional Analysis for Proteomics Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Most Frequently Asked Questions in the Proteomics Market Research Industry:

➠ Who leads the Proteomics industry and what's their competitive positioning regarding capacity, performance, and profitability?

➠ What growth opportunities and market challenges do Proteomics market vendors face?

➠ Which segments show the highest growth potential and market share distribution?

➠ What factors are driving or limiting Proteomics market growth?

➠ What are the dominant sales and distribution strategies in the Proteomics industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.